Explore the GORE® VIABAHN® stent with Heparin Bioactive Surface, proven in complex PAD cases like SFA CTO, providing high patency and fewer interventions.

Designed to expand to every demand, the GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) offers proven procedural success and long-term outcomes 1-3 through flexibility, strength and accuracy to treat aortoiliac occlusive disease.

Bile-resistant, ePTFE lining designed to sustain patency due to reduced in-stent stenosis. Uncovered portion for sustained portal vein and shunt perfusion. Optimized radial force and flexibility engineered for conformability in tortuous anatomy.

The GORE VIABIL Biliary Endoprosthesis is proven to minimize the risk of reintervention. A non-foreshortening design, higher primary patency rates, and optimal conformance to ductal anatomy are just some of the reasons this stent may be right for your endoscopic biliary needs.

FLAGSTAFF, Ariz. (August 2, 2016) – W. L. Gore & Associates, Inc. (Gore) today announced the U.S. Food and Drug Administration (FDA) approval of the GORE® TIGRIS® Vascular Stent, a dual-component stent with a unique fluoropolymer / nitinol design.

The first fully-covered metal stent with a proprietary pull-line deployment system – it is obvious why GORE® VIABIL® Biliary Endoprosthesis is a trusted leader in fully-covered, self-expandable metal stents in the Interventional Endoscopy Market. 3

FLAGSTAFF, Ariz. (January 24, 2019) – The GORE® TIGRIS® Vascular Stent, a flexible self-expanding stent to treat peripheral arterial disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA) developed by W. L. Gore & Associates, Inc. (Gore), demonstrated that it is a safe and effective device that can be ...

The GORE® ACTIVE CONTROL System enhances the exceptional conformability of the stent graft; facilitating the optimized wall apposition that the Conformable GORE® TAG® Device is renowned for even in complex anatomies, such as acute aortic angles.

The GORE ® VIABAHN ® Endoprosthesis with Heparin Bioactive Surface is indicated for improving blood flow in patients with symptomatic peripheral arterial disease in superficial femoral artery in-stent restenotic lesions up to 270 mm in length with reference vessel diameters ranging from 4.0 – 6.5 mm.

Best practices and treatment considerations for using stent-grafts. The GORE VIABAHN Device has been used for percutaneous management of long, complex femoropopliteal occlusive disease with favorable results, as demonstrated in numerous clinical trials.

The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis is indicated for the treatment of de novo or restenotic lesions found in iliac arteries with reference vessel diameters ranging from 5 mm...

The GORE TAG Thoracic Branch Endoprosthesis is a catheter-based stent graft that is used to repair damage to the descending thoracic aorta.

Learn about the VIABAHN® Device family of covered stent grafts, designed for flexibility in treating complex PAD, including aortoiliac occlusive disease (AIOD).

Proven across a broad range of complex cases, the versatility of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface* enables you to deliver high patency and durable outcomes to minimize interventions for your patients. The GORE® VIABAHN® Endoprosthesis is a leader among stent grafts.†.

The Gore study will investigate how an endovascular stent graft, delivered via catheter, may be used to line the dissected portion of the ascending aorta as a less-invasive alternative to open surgical repair.

December 20, 2023—Gore & Associates announced the commencement of the ARISE II pivotal trial. The study is investigating treatments for pathologies involving the ascending aorta using endovascular repair with the Gore Ascending Stent Graft rather than traditional open surgery.

January 31, 2024 — As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. L. Gore & Associates, Inc. (Gore) announced recent FDA approval of a lower profile GORE VIABAHN VBX Balloon Expandable Endoprosthesis (VBX Stent Graft).

View the catalogue numbers and specifications unique to Europe for the GORE® VIABAHN® Endoprosthesis.

Jul 23, 2010 · The GORE VIABAHN® Endoprosthesis with Heparin Bioactive Surface is approved for both the SFA and iliac artery. The stent-graft features the addition of proprietary heparin-bonded technology to the proven combination of ePTFE and nitinol.

The GORE® VIABAHN® Device is a leader among stent grafts. Decades of partnership with clinicians around the globe has resulted in unparalleled performance across multiple indications. The GORE® VIABAHN® Device features: Lengths up to 25 cm; Low profile design; Radiopaque markers; Proven CBAS® Heparin Surface technology ǂ